TILT Biotherapeutics
Developer of a biotechnology platform intended to develop oncolytic immunotherapies that will modify the tumor microenvironment and eliminate its ability to suppress immune responses to cancer. The co...
Valuation
$0
Share Price
N/A
Total Raised
$82M
Last Round
N/A